BAKX Therapeutics is a provider of cancer treatment.
BAKX Therapeutics has raised $25.0M in total funding. The most recent round was Series A. The last funding was announced in November 2021.
BAKX Therapeutics's investors include Sherpa Healthcare Partners, Ipsen, AB Magnitude Ventures Group.
BAKX Therapeutics is headquartered in Boston, United States.
BAKX Therapeutics is a provider of cancer treatment.
BAKX Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BAKX Therapeutics — Funding & Investors." VCBacked, November 18, 2021, https://www.vcbacked.co/company/bakx-therapeutics. Accessed August 14, 2026.
VCBacked. (2021). BAKX Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/bakx-therapeutics
{{cite web |title=BAKX Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/bakx-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated